GXP-PHARMA SUPPORT ApS
CVR 36033347Private limited company (ApS)Anden teknisk rådgivning (711290)SorøFounded 3 Jul 2014
Employees
1
CVR registry, Jul 2026
0 (0%) over 12 months
Gross profit
128,5K
DKK, annual report 2025
Result
-314,5K
DKK, annual report 2025
Equity
58,7K
DKK, annual report 2025
Who Is Behind It
- Owner
CHRIBEN ApSCVR 29535574, 100% of capital and votes, since 3 Jul 2014
- Ultimate controller
- Jan Laursenthrough CHRIBEN ApS, a Dandex estimate
- Director
Lone Cleveland Andersensince 3 Jul 2014
Equity of 58,7K DKK was below half the share capital of 500K DKK at 31 Dec 2025. Under the Companies Act (selskabsloven § 119) management must then account for the company's finances at a general meeting. Dandex estimate, computed 20 Oct 2026.
Ownership
- CHRIBEN ApS
CVR 29535574100% of capital and votessince 3 Jul 2014
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Control Chain
Ultimate controller
Holds 100% of capital and votes in CHRIBEN ApS, since 25 Apr 2006
Capital100%Votes100%Holding company
CVR 29535574Private limited company (ApS)
Holds 100% of capital and votes in GXP-PHARMA SUPPORT ApS, since 3 Jul 2014
Capital100%Votes100%This company
GXP-PHARMA SUPPORT ApS
CVR 36033347
People
Current (3)
- Lone Cleveland AndersenExecutive board since 3 Jul 2014, Board of directors since 3 Jul 2014
- Jan LaursenBoard of directors since 3 Jul 2014
- Iben Cleveland LaursenBoard of directors since 3 Jul 2014
Founders (1)
- CHRIBEN ApSFounded 3 Jul 2014, holds a current role
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Network
Roles Over Time
- Lone Cleveland Andersen: Executive board, 3 Jul 2014 to today; Board of directors, 3 Jul 2014 to today.
- Jan Laursen: Board of directors, 3 Jul 2014 to today.
- Iben Cleveland Laursen: Board of directors, 3 Jul 2014 to today.
3 Jul 2014 to 20 Oct 2026.
Financials
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 1.095 | 211 | 361 | -263 | 129 |
| Operating profit | +153 | -58 | +127 | -348 | -396 |
| Result for the year | +426 | -346 | +367 | -166 | -314 |
| Equity | 1.118 | 772 | 1.140 | 373 | 59 |
| Total assets | 2.177 | 1.105 | 1.481 | 646 | 198 |
| Employees (average) | 1 | 1 | 1 | 1 | 1 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Annual Reports
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 7 Apr 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 21 Apr 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 4 Apr 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 13 Apr 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 21 Apr 2022
Changes
All changesRegistration
- Address
- Energivej 3
4180 Sorø
Sorø Municipality - CVR record last changed
- 1 Oct 2026
- Data read
- 20 Oct 2026
Production Units
1 registered in CVR.
- GXP-PHARMA SUPPORT ApS
P-number 1019528703Energivej 3, 4180 Sorø
Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Ask About GXP-PHARMA SUPPORT ApS With AI
Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.